The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Open accessAbstract
BACKGROUND: Aberrant energy metabolism is a hallmark of cancer. To fulfill the increased energy requirements, tumor cells secrete cytokines/factors inducing muscle and fat degradation in cancer patients, a condition known as cancer cachexia. It accounts for nearly 20% of all cancer-related deaths. However, the mechanistic basis of cancer cachexia and therapies targeting cancer cachexia thus far remain elusive. A ketogenic diet, a high-fat and low-carbohydrate diet that elevates circulating levels of ketone bodies (i.e., acetoacetate, β-hydroxybutyrate, and acetone), serves as an alternative energy source. It has also been proposed that a ketogenic diet leads to systemic metabolic changes. Keeping in view the significant role of metabolic alterations in cancer, we hypothesized that a ketogenic diet may diminish glycolytic flux in tumor cells to alleviate cachexia syndrome and, hence, may provide an efficient therapeutic strategy. RESULTS: We observed reduced glycolytic flux in tumor cells upon treatment with ketone bodies. Ketone bodies also diminished glutamine uptake, overall ATP content, and survival in multiple pancreatic cancer cell lines, while inducing apoptosis. A decrease in levels of c-Myc, a metabolic master regulator, and its recruitment on glycolytic gene promoters, was in part responsible for the metabolic phenotype in tumor cells. Ketone body-induced intracellular metabolomic reprogramming in pancreatic cancer cells also leads to a significantly diminished cachexia in cell line models. Our mouse orthotopic xenograft models further confirmed the effect of a ketogenic diet in diminishing tumor growth and cachexia. CONCLUSIONS: Thus, our studies demonstrate that the cachectic phenotype is in part due to metabolic alterations in tumor cells, which can be reverted by a ketogenic diet, causing reduced tumor growth and inhibition of muscle and body weight loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Bioinformatics and Computational Biology Solutions Using R and Bioconductor
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0 · Cited by 3,289
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
HMDB 3.0—The Human Metabolome Database in 2013
Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1065 · Cited by 2,845
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“Most cancer cells demonstrate an increase in glucose uptake, a higher rate of glycolysis, and an increase in lactate secretion despite the presence of oxygen, a phenomenon known as the Warburg effect [8].”
BackgroundGlutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Tisdale, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc927 · Cited by 982
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 929
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 850
Choline metabolism in malignant transformation
Glunde, K., Bhujwalla, Z. M., & Ronen, S. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3162 · Cited by 823
Modelling Myc inhibition as a cancer therapy
Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 817
HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation
Gordan, J. D., Thompson, C. B., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.006 · Cited by 803
Diet, nutrition and the prevention of cancer
Key, T. J., Schatzkin, A., Willett, W. C., Allen, N. E., Spencer, E. A., & Travis, R. C. (2004) · Public Health Nutrition · doi:10.1079/phn2003588 · Cited by 648
Metabolite identification via the Madison Metabolomics Consortium Database
Cui, Q., Lewis, I. A., Hegeman, A. D., Anderson, M. E., Li, J., Schulte, C. F., Westler, W. M., Eghbalnia, H. R., Sussman, M. R., & Markley, J. L. (2008) · Nature Biotechnology · doi:10.1038/nbt0208-162 · Cited by 632
The Efficacy of the Ketogenic Diet—1998: A Prospective Evaluation of Intervention in 150 Children
Freeman, J. M., Vining, E. P. G., Pillas, D. J., Pyzik, P. L., Casey, J. C., & Kelly, L. A. M. T. (1998) · Pediatrics · doi:10.1542/peds.102.6.1358 · Cited by 612
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
Inui, A. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.2.72 · Cited by 579
Shaw, R. J. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.005 · Cited by 550
Redox Regulation in Cancer: A Double‐edged Sword with Therapeutic Potential
Acharya, A., Das, I., Chandhok, D., & Saha, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.1.10095 · Cited by 486
A high-fat, ketogenic diet induces a unique metabolic state in mice
Kennedy, A. R., Pissios, P., Otu, H., Xue, B., Asakura, K., Furukawa, N., Marino, F. E., Liu, F.-F., Kahn, B. B., Libermann, T. A., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00717.2006 · Cited by 420
The Ketogenic Diet: One Decade Later
Freeman, J. M., Kossoff, E. H., & Hartman, A. L. (2007) · Pediatrics · doi:10.1542/peds.2006-2447 · Cited by 364
Willcox, D. C., Willcox, B. J., Todoriki, H., & Suzuki, M. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10718117 · Cited by 311
The cancer anorexia-cachexia syndrome.
Nelson, K. A., Walsh, D., & Sheehan, F. A. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.213 · Cited by 265
De Meyer, T., Sinnaeve, D., Van Gasse, B., Tsiporkova, E., Rietzschel, E. R., De Buyzere, M. L., Gillebert, T. C., Bekaert, S., Martins, J. C., & Van Criekinge, W. (2008) · Analytical Chemistry · doi:10.1021/ac7025964 · Cited by 247
Gao, J., Tarcea, V. G., Karnovsky, A., Mirel, B. R., Weymouth, T. E., Beecher, C. W., Cavalcoli, J. D., Athey, B. D., Omenn, G. S., Burant, C. F., et al. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq048 · Cited by 231
Chaika, N. V., Gebregiworgis, T., Lewallen, M. E., Purohit, V., Radhakrishnan, P., Liu, X., Zhang, B., Mehla, K., Brown, R. B., Caffrey, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203339109 · Cited by 227
Self-citationPRIMe: A Web Site That Assembles Tools for Metabolomics and Transcriptomics
Akiyama, K., Chikayama, E., Yuasa, H., Shimada, Y., Tohge, T., Shinozaki, K., Hirai, M. Y., Sakurai, T., Kikuchi, J., & Saito, K. (2008) · In Silico Biology: Journal of Biological Systems Modeling and Multi-Scale Simulation · doi:10.3233/isb-00362 · Cited by 206
Is there a role for carbohydrate restriction in the treatment and prevention of cancer?
Klement, R. J., & Kämmerer, U. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-75 · Cited by 206
Eley, H. L., Russell, S. T., Baxter, J. H., Mukerji, P., & Tisdale, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2007 · Cited by 204
GLUT1 as a therapeutic target in hepatocellular carcinoma
Amann, T., & Hellerbrand, C. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903307509 · Cited by 204
A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.
Tayek, J. A. (1992) · Journal of the American College of Nutrition · doi:10.1080/07315724.1992.10718249 · Cited by 194
Autophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress
Marino, M. L., Pellegrini, P., Di Lernia, G., Djavaheri-Mergny, M., Brnjic, S., Zhang, X., Hägg, M., Linder, S., Fais, S., Codogno, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339127 · Cited by 184
Reduced Pain and Inflammation in Juvenile and Adult Rats Fed a Ketogenic Diet
Ruskin, D. N., Kawamura, M., & Masino, S. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008349 · Cited by 181
Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester
Hashim, S. A., & VanItallie, T. B. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046599 · Cited by 167
MVAPACK: A Complete Data Handling Package for NMR Metabolomics
Worley, B., & Powers, R. (2014) · ACS Chemical Biology · doi:10.1021/cb4008937 · Cited by 123
Self-citationAre purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?
Masino, S. A., & Geiger, J. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.009 · Cited by 116
Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
Singh, P. K., Behrens, M. E., Eggers, J. P., Cerny, R. L., Bailey, J. M., Shanmugam, K., Gendler, S. J., Bennett, E., & Hollingsworth, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805036200 · Cited by 90
Self-citationCitrate induces apoptotic cell death: a promising way to treat gastric carcinoma?
Lu, Y., Zhang, X., Zhang, H., Lan, J. X., Huang, G., Varin, E., Lincet, H., Poulain, L., & Icard, P. (2011) · PubMed · Cited by 86
The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF
Behrens, M. E., Grandgenett, P. M., Bailey, J. M., Singh, P. K., Yi, C.-H., Yu, F., & Hollingsworth, M. A. (2010) · Oncogene · doi:10.1038/onc.2010.327 · Cited by 81
Self-citationCancer anorexia - cachexia syndrome.
Muliawati, Y., Haroen, H., & Rotty, L. W. A. (2012) · PubMed · Cited by 70
Improved identification of metabolites in complex mixtures using HSQC NMR spectroscopy
Xi, Y., de Ropp, J. S., Viant, M. R., Woodruff, D. L., & Yu, P. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.03.024 · Cited by 66
Revisiting Protocols for the NMR Analysis of Bacterial Metabolomes
Powers, R., Halouska, S., Zhang, B., Gaupp, R., Lei, S., Snell, E., Fenton, R. J., Barletta, R. G., & Somerville, G. A. (2013) · Journal of Integrated OMICS · doi:10.5584/jiomics.v3i2.139 · Cited by 61
Self-citationIntravesical Instillation of c-MYC Inhibitor KSI-3716 Suppresses Orthotopic Bladder Tumor Growth
Jeong, K., Kim, K., Seo, H.-H., Shin, S.-P., Ahn, K.-O., Ji, M.-J., Park, W. S., Kim, I.-H., Lee, S.-J., & Seo, H. K. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.07.019 · Cited by 55
Iwamura, T., TANIGUCHI, S., Kitamura, N., Yamanari, H., KOJIMA, A., Hidaka, K., Setoguchi, T., & Katsuki, T. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb01030.x · Cited by 47
HDAC inhibitors in cancer care.
Tofilon, P. J., & Camphausen, K. A. (2010) · PubMed · Cited by 47
Raykov, Z., Grekova, S. P., Bour, G., Lehn, J., Giese, N. A., Nicolau, C. S., & Aprahamian, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28597 · Cited by 44
Roomi, M. W., Ivanov, V. O., Kalinovsky, T., Niedzwiecki, A., & Rath, M. (2006) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01309.x · Cited by 28
Cited by
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610
Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.004 · Cited by 540
Self-citationKetogenic diet in the treatment of cancer – Where do we stand?
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.026 · Cited by 464
Cancer-associated adipocytes: key players in breast cancer progression
Wu, Q., Li, B., Li, Z., Li, J., Sun, S., & Sun, S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0778-6 · Cited by 462
Tumor glycolysis, an essential sweet tooth of tumor cells
Paul, S., Ghosh, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.007 · Cited by 449
Metadata
- Authors
- Shukla, S. K., Gebregiworgis, T., Purohit, V., Chaika, N. V., Gunda, V., Radhakrishnan, P., Mehla, K., Pipinos, I. I., Powers, R., Yu, F., & Singh, P. K.
- Venue
- Cancer & Metabolism
- Published
- 2014-09-01
- Volume
- 2
- Issue
- 1
- Pages
- 18-18
- ISSN
- 2049-3002 (ISSN-L)
- OpenAlex
- W2155631120
- Cited by
- 255
- References
- 61
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.